Sebastian Patzke

Oslo, 0275, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

A Multi-Layered Proteogenomic Framework for the Prioritization of Cell Surface Therapeutic Targets: Proof-of-Concept for Metastatic Colorectal Cancer.

A Multi-Layered Proteogenomic Framework for the Prioritization of Cell Surface Therapeutic Targets: Proof-of-Concept for Metastatic Colorectal Cancer.

Journal: Cancers

Published: May 29, 2026

Comprehensive analysis of 177Lu-lilotomab satetraxetan in lymphoma cell lines: Implications for precision radioimmunotherapy and combination schemes.

Comprehensive analysis of 177Lu-lilotomab satetraxetan in lymphoma cell lines: Implications for precision radioimmunotherapy and combination schemes.

Journal: British journal of haematology

Published: May 22, 2025

CSPP1 stabilizes growing microtubule ends and damaged lattices from the luminal side.

CSPP1 stabilizes growing microtubule ends and damaged lattices from the luminal side.

Journal: The Journal of cell biology

Published: August 12, 2022

CCDC66 regulates primary cilium length and signaling via interactions with transition zone and axonemal proteins.

CCDC66 regulates primary cilium length and signaling via interactions with transition zone and axonemal proteins.

Journal: Journal of cell science

Published: June 10, 2022

3D-Structured Illumination Microscopy of Centrosomes in Human Cell Lines.

3D-Structured Illumination Microscopy of Centrosomes in Human Cell Lines.

Journal: Bio-protocol

Published: November 22, 2021

Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro.

Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro.

Journal: PloS one

Published: November 06, 2020

CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels.

CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels.

Journal: eLife

Published: October 05, 2020

Photochemically-Induced Release of Lysosomal Sequestered Sunitinib: Obstacles for Therapeutic Efficacy.

Photochemically-Induced Release of Lysosomal Sequestered Sunitinib: Obstacles for Therapeutic Efficacy.

Journal: Cancers

Published: January 07, 2020

177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma.

177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 08, 2019

The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines.

The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines.

Journal: Frontiers in oncology

Published: July 21, 2019

Loss of CBY1 results in a ciliopathy characterized by features of Joubert syndrome.

Loss of CBY1 results in a ciliopathy characterized by features of Joubert syndrome.

Journal: Human mutation

Published: June 20, 2019

The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest.

The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest.

Journal: Leukemia

Published: March 09, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026